Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts

Journal of Cell Biology

Volumn 204, Issue 6, 2014, Pages 1063-1074

  Kim, Jung Ha ^a   Kim, Kabsun ^a   Youn, Bang Ung ^a   Lee, Jongwon ^a   Kim, Inyoung ^a   Shin, Hong In ^b   Akiyama, Haruhiko ^c   Choi, Yongwon ^d   Kim, Nacksung ^a  

^a Chonnam National University Medical School   (South Korea)

^b Kyungpook National University   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 1; KRUPPEL LIKE FACTOR 4; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CELL COUNT; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE TARGETING; HOMEOSTASIS; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RNA INTERFERENCE; UPREGULATION; VITAMIN D RESPONSIVE ELEMENT;

ANIMALS; BONE AND BONES; CALCITRIOL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMEOSTASIS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; PROMOTER REGIONS, GENETIC; RANK LIGAND; RECEPTORS, CALCITRIOL;

EID: 84896277006     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201308102     Document Type: Article

References (37)

1. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D.M. Anderson, and T. Suda. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor KB (RANK) receptors. J. Exp. Med. 190:1741-1754. http://dx.doi.org/10.1084/jem.190.12.1741
2. Baek, W.Y., M.A. Lee, J.W. Jung, S.Y. Kim, H. Akiyama, B. de Crombrugghe, and J.E. Kim. 2009. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J. Bone Miner. Res. 24:1055-1065. http://dx.doi.org/10.1359/jbmr.081248
3. Balga, R., A. Wetterwald, J. Portenier, S. Dolder, C. Mueller, and W. Hofstetter. 2006. Tumor necrosis factor-α: alternative role as an inhibitor of osteoclast formation in vitro. Bone. 39:325-335. http://dx.doi.org/10.1016/j .bone.2006.02.056
4. Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature. 423:337-342. http://dx.doi.org/10.1038/nature01658
5. Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025-1036. http://dx.doi.org/10.1101/gad.13.8.1025
6. Evans, P.M., and C. Liu. 2008. Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys. Sin. (Shanghai). 40:554-564. http://dx.doi.org/10.1111/j.1745-7270.2008.00439.x
7. Evans, P.M., X. Chen, W. Zhang, and C. Liu. 2010. KLF4 interacts with β-catenin/TCF4 and blocks p300/CBP recruitment by β-catenin. Mol. Cell. Biol. 30:372-381. http://dx.doi.org/10.1128/MCB.00063-09
8. Glass, D.A. II, P. Bialek, J.D. Ahn, M. Starbuck, M.S. Patel, H. Clevers, M.M. Taketo, F. Long, A.P. McMahon, R.A. Lang, and G. Karsenty. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell. 8:751-764. http://dx.doi.org/10 .1016/j.devcel.2005.02.017
9. Hinoi, E., S. Fujimori, L. Wang, H. Hojo, K. Uno, and Y. Yoneda. 2006. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J. Biol. Chem. 281:18015-18024. http://dx.doi.org/10.1074/jbc.M600603200
10. Hofbauer, L.C., F. Gori, B.L. Riggs, D.L. Lacey, C.R. Dunstan, T.C. Spelsberg, and S. Khosla. 1999. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. 140:4382-4389.
11. Kanai, M., D. Wei, Q. Li, Z. Jia, J. Ajani, X. Le, J. Yao, and K. Xie. 2006. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res. 12:6395-6402. http://dx.doi.org/10.1158/1078-0432.CCR-06-1034
12. Khosla, S. 2001. Minireview: the OPG/RANKL/RANK system. Endocrinology. 142:5050-5055. http://dx.doi.org/10.1210/endo.142.12.8536
13. Kim, Y.J., B.G. Kim, S.J. Lee, H.K. Lee, S.H. Lee, H.M. Ryoo, and J.Y. Cho. 2007. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. J. Cell. Physiol. 211:253-260. http://dx.doi.org/10 .1002/jcp.20933
14. 3 augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem. Biophys. Res. Commun. 290:650-655. http://dx.doi.org/10.1006/ bbrc.2001.6251
15. Kitazawa, R., S. Kitazawa, and S. Maeda. 1999. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim. Biophys. Acta. 1445:134-141. http://dx.doi.org/10.1016/S0167-4781(99)00032-9
16. Komori, T. 2005. Regulation of skeletal development by the Runx family of transcription factors. J. Cell. Biochem. 95:445-453. http://dx.doi.org/10 .1002/jcb.20420
17. Komori, T. 2011. Signaling networks in RUNX2-dependent bone development. J. Cell. Biochem. 112:750-755. http://dx.doi.org/10.1002/jcb.22994
18. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755-764. http://dx.doi.org/ 10.1016/S0092-8674(00)80258-5
19. Kubota, T., T. Michigami, and K. Ozono. 2009. Wnt signaling in bone metabolism. J. Bone Miner. Metab. 27:265-271. http://dx.doi.org/10.1007/ s00774-009-0064-8
20. 3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1α and receptor activator of NF-kB ligand production in osteoblasts. J. Immunol. 169:2374-2380.
21. Lee, S.H., T.S. Kim, Y. Choi, and J. Lorenzo. 2008. Osteoimmunology: cytokines and the skeletal system. BMB Rep. 41:495-510. http://dx.doi.org/10 .5483/BMBRep.2008.41.7.495
22. Lengner, C.J., H.A. Steinman, J. Gagnon, T.W. Smith, J.E. Henderson, B.E. Kream, G.S. Stein, J.B. Lian, and S.N. Jones. 2006. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol. 172:909-921. http://dx.doi.org/10.1083/jcb.200508130
23. Liu, W., S. Toyosawa, T. Furuichi, N. Kanatani, C. Yoshida, Y. Liu, M. Himeno, S. Narai, A. Yamaguchi, and T. Komori. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155:157-166. http://dx.doi.org/10.1083/ jcb.200105052
24. Maruyama, Z., C.A. Yoshida, T. Furuichi, N. Amizuka, M. Ito, R. Fukuyama, T. Miyazaki, H. Kitaura, K. Nakamura, T. Fujita, et al. 2007. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 236:1876-1890. http://dx.doi.org/10.1002/dvdy.21187
25. Michikami, I., T. Fukushi, M. Tanaka, H. Egusa, Y. Maeda, T. Ooshima, S. Wakisaka, and M. Abe. 2012. Krüppel-like factor 4 regulates membranous and endochondral ossification. Exp. Cell Res. 318:311-325. http:// dx.doi.org/10.1016/j.yexcr.2011.12.013
26. 3 or parathyroid hormone. J. Biol. Chem. 274:19301-19308. http://dx.doi .org/10.1074/jbc.274.27.19301
27. Song, L., M. Liu, N. Ono, F.R. Bringhurst, H.M. Kronenberg, and J. Guo. 2012. Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes. J. Bone Miner. Res. 27:2344-2358. http:// dx.doi.org/10.1002/jbmr.1694
28. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357. http://dx.doi.org/10.1210/edrv.20.3.0367
29. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3:889-901. http://dx.doi.org/10 .1016/S1534-5807(02)00369-6
30. Takeda, S., T. Yoshizawa, Y. Nagai, H. Yamato, S. Fukumoto, K. Sekine, S. Kato, T. Matsumoto, and T. Fujita. 1999. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology. 140:1005-1008. http://dx.doi.org/10.1210/endo.140.2.6673
31. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508. http://dx.doi.org/10.1126/science.289.5484.1504
32. Thomas, G.P., S.U. Baker, J.A. Eisman, and E.M. Gardiner. 2001. Changing RANKL/ OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 170:451-460. http://dx.doi.org/10.1677/joe.0.1700451
33. Walsh, M.C., N. Kim, Y. Kadono, J. Rho, S.Y. Lee, J. Lorenzo, and Y. Choi. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24:33-63. http://dx.doi.org/10.1146/ annurev.immunol.24.021605.090646
34. Yet, S.F., M.M. McA'Nulty, S.C. Folta, H.W. Yen, M. Yoshizumi, C.M. Hsieh, M.D. Layne, M.T. Chin, H. Wang, M.A. Perrella, et al. 1998. Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem. 273:1026-1031. http://dx.doi.org/10.1074/jbc.273.2.1026
35. Zaidi, S.K., A.J. Sullivan, R. Medina, Y. Ito, A.J. van Wijnen, J.L. Stein, J.B. Lian, and G.S. Stein. 2004. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23:790-799. http://dx.doi.org/10.1038/sj.emboj.7600073
36. Zhang, W., J.M. Shields, K. Sogawa, Y. Fujii-Kuriyama, and V.W. Yang. 1998. The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J. Biol. Chem. 273:17917-17925. http://dx.doi.org/10.1074/jbc.273.28.17917
37. Zhang, W., X. Chen, Y. Kato, P.M. Evans, S. Yuan, J. Yang, P.G. Rychahou, V.W. Yang, X. He, B.M. Evers, and C. Liu. 2006. Novel cross talk of Kruppel-like factor 4 and β-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol. 26:2055-2064. http://dx.doi .org/10.1128/MCB.26.6.2055-2064.2006